etoposide has been researched along with Bowel Diseases, Inflammatory in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drach, M; Gaggl, I; Jan Wiegers, G; Kaufmann, M; Peschel, I; Thuille, N; Tischner, D; Tuzlak, S; Villunger, A | 1 |
1 other study(ies) available for etoposide and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Defective cell death signalling along the Bcl-2 regulated apoptosis pathway compromises Treg cell development and limits their functionality in mice.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; CD4-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Etoposide; Female; Flow Cytometry; Forkhead Transcription Factors; Gene Expression Profiling; Green Fluorescent Proteins; Inflammatory Bowel Diseases; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; T-Lymphocytes, Regulatory; Thymus Gland | 2012 |